245 related articles for article (PubMed ID: 29801893)
1. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K
J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893
[No Abstract] [Full Text] [Related]
2. [Transthyretin familial amyloid polyneuropathy - three Hungarian cases with rare mutations (His88Arg and Phe33Leu)].
Csillik A; Pozsonyi Z; Soós K; Balogh I; Bodó I; Arányi Z
Ideggyogy Sz; 2016 Jul; 69(7-8):245-253. PubMed ID: 29465889
[TBL] [Abstract][Full Text] [Related]
3. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
4. [What gnaws at the heart and gets on the nerves].
Kristen AV
Internist (Berl); 2018 Nov; 59(11):1208-1213. PubMed ID: 30039176
[TBL] [Abstract][Full Text] [Related]
5. Corneal confocal microscopy and familial amyloidotic polyneuropathy.
Bouaich K; Dufrane R; Youssfi A; Slim E; Ehongo A
J Fr Ophtalmol; 2020 Feb; 43(2):e81-e84. PubMed ID: 31870669
[No Abstract] [Full Text] [Related]
6. Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy.
Low SC; Tan CY; Md Sari NA; Ahmad-Annuar A; Wong KT; Lin KP; Shahrizaila N; Tan CT; Goh KJ
Amyloid; 2019; 26(sup1):7-8. PubMed ID: 31343308
[No Abstract] [Full Text] [Related]
7. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
Cruz MW; Schmidt H; Botteman MF; Carter JA; Chopra AS; Stewart M; Hopps M; Fallet S; Amass L
Amyloid; 2017 Mar; 24(sup1):109-110. PubMed ID: 28434345
[No Abstract] [Full Text] [Related]
9. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
Obici L; Berk JL; González-Duarte A; Coelho T; Gillmore J; Schmidt HH; Schilling M; Yamashita T; Labeyrie C; Brannagan TH; Ajroud-Driss S; Gorevic P; Kristen AV; Franklin J; Chen J; Sweetser MT; Wang JJ; Adams D
Amyloid; 2020 Sep; 27(3):153-162. PubMed ID: 32131641
[No Abstract] [Full Text] [Related]
10. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S
No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722
[TBL] [Abstract][Full Text] [Related]
11. Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin.
Cassereau J; Lavigne C; Letournel F; Ghali A; Verny C; Dubas F; Devière F; Nicolas G
J Peripher Nerv Syst; 2008 Sep; 13(3):251-4. PubMed ID: 18844793
[No Abstract] [Full Text] [Related]
12. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V
Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425
[No Abstract] [Full Text] [Related]
13. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
[No Abstract] [Full Text] [Related]
14. Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid.
Lorenzoni PJ; Giugno VR; Ducci RD; Werneck LC; Kay CSK; Scola RH
Acta Neurol Belg; 2023 Aug; 123(4):1655-1657. PubMed ID: 36840806
[No Abstract] [Full Text] [Related]
15. Disease-Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.
Ueda M; Misumi Y; Nomura T; Tasaki M; Yamakawa S; Obayashi K; Yamashita T; Ando Y
Ann Neurol; 2024 Feb; 95(2):230-236. PubMed ID: 38053464
[TBL] [Abstract][Full Text] [Related]
16. [Transthyretin familial amyloid polyneuropathy].
Kopishinskaya SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
[TBL] [Abstract][Full Text] [Related]
17. Transthyretin deposition in familial amyloidotic polyneuropathy.
Saraiva MJ; Magalhaes J; Ferreira N; Almeida MR
Curr Med Chem; 2012; 19(15):2304-11. PubMed ID: 22471982
[TBL] [Abstract][Full Text] [Related]
18. Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp.
Misumi Y; Doki T; Ueda M; Obayashi K; Tasaki M; Tamura A; Ando Y
Amyloid; 2014 Sep; 21(3):216-7. PubMed ID: 24953234
[No Abstract] [Full Text] [Related]
19. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.
Waddington-Cruz M; Schmidt H; Botteman MF; Carter JA; Stewart M; Hopps M; Fallet S; Amass L
Orphanet J Rare Dis; 2019 Feb; 14(1):34. PubMed ID: 30736835
[TBL] [Abstract][Full Text] [Related]
20. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
